Risk factors and outcomes of inpatients with carbapenem-resistant Pseudomonas aeruginosa bloodstream infections in China: a 9-year trend and multicenter cohort study
出版年份 2023 全文链接
标题
Risk factors and outcomes of inpatients with carbapenem-resistant Pseudomonas aeruginosa bloodstream infections in China: a 9-year trend and multicenter cohort study
作者
关键词
-
出版物
Frontiers in Microbiology
Volume 14, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2023-05-16
DOI
10.3389/fmicb.2023.1137811
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Infectious Diseases Society of America 2022 Guidance on the Treatment of Extended-Spectrum β-lactamase Producing Enterobacterales (ESBL-E), Carbapenem-Resistant Enterobacterales (CRE), and Pseudomonas aeruginosa with Difficult-to-Treat Resistance (DTR-P. aeruginosa)
- (2022) Pranita D. Tamma et al. CLINICAL INFECTIOUS DISEASES
- Carbapenemase-producing Pseudomonas aeruginosa –an emerging challenge
- (2022) Fred C. Tenover et al. Emerging Microbes & Infections
- Real-Life Use of Ceftolozane/Tazobactam for the Treatment of Bloodstream Infection Due to Pseudomonas aeruginosa in Neutropenic Hematologic Patients: a Matched Control Study (ZENITH Study)
- (2022) Alba Bergas et al. Microbiology Spectrum
- Emergence and Expansion of a Carbapenem-Resistant Pseudomonas aeruginosa Clone Are Associated with Plasmid-Borne blaKPC-2 and Virulence-Related Genes
- (2021) Yanyan Hu et al. mSystems
- Socioeconomic burden of bloodstream infections caused by carbapenem-resistant and carbapenem-susceptible Pseudomonas aeruginosa in China
- (2021) Kai Yang et al. Journal of Global Antimicrobial Resistance
- The Epidemiology and Pathogenesis and Treatment of Pseudomonas aeruginosa Infections: An Update
- (2021) Dan Reynolds et al. DRUGS
- Bloodstream Infections Caused by Klebsiella pneumoniae Carbapenemase–Producing P. aeruginosa Sequence Type 463, Associated With High Mortality Rates in China: A Retrospective Cohort Study
- (2021) Hangbin Hu et al. Frontiers in Cellular and Infection Microbiology
- Risk Factors and Outcomes of Antibiotic-resistant Pseudomonas aeruginosa Bloodstream Infection in Adult Patients With Acute Leukemia
- (2020) Yuanqi Zhao et al. CLINICAL INFECTIOUS DISEASES
- A retrospective analysis of Pseudomonas aeruginosa bloodstream infections: prevalence, risk factors, and outcome in carbapenem-susceptible and -non-susceptible infections
- (2019) Qingyi Shi et al. Antimicrobial Resistance and Infection Control
- Resilience of the Pitt Bacteremia Score: Three Decades and Counting
- (2019) Majdi N Al-Hasan et al. CLINICAL INFECTIOUS DISEASES
- High frequency of the exoU+/exoS+ genotype associated with multidrug-resistant “high-risk clones” of Pseudomonas aeruginosa clinical isolates from Peruvian hospitals
- (2019) Gertrudis Horna et al. Scientific Reports
- Epidemiology and Treatment of Multidrug-Resistant and Extensively Drug-Resistant Pseudomonas aeruginosa Infections
- (2019) Juan P. Horcajada et al. CLINICAL MICROBIOLOGY REVIEWS
- OUP accepted manuscript
- (2018) CLINICAL INFECTIOUS DISEASES
- Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis
- (2018) Evelina Tacconelli et al. LANCET INFECTIOUS DISEASES
- Carbapenem-resistant and cephalosporin-susceptible Pseudomonas aeruginosa: a notable phenotype in patients with bacteremia
- (2018) Shuang Li et al. Infection and Drug Resistance
- Risk factors and predictors of carbapenem-resistant Pseudomonas aeruginosa and Acinetobacter baumannii mortality in critically ill bacteraemic patients over a 6-year period (2010–15): antibiotics do matter
- (2017) Matthaios Papadimitriou-Olivgeris et al. JOURNAL OF MEDICAL MICROBIOLOGY
- Risk factors and clinical significance of bacteremia caused by Pseudomonas aeruginosa resistant only to carbapenems
- (2017) Chia-Hsin Lee et al. JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION
- Time-to-positivity of blood culture: An independent prognostic factor of monomicrobial Pseudomonas aeruginosa bacteremia
- (2017) Poh-Chang Tang et al. JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION
- Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective cohort study
- (2017) Belén Gutiérrez-Gutiérrez et al. LANCET INFECTIOUS DISEASES
- Global Dissemination ofblaKPCinto Bacterial Species beyond Klebsiella pneumoniae andIn VitroSusceptibility to Ceftazidime-Avibactam and Aztreonam-Avibactam
- (2016) Krystyna M. Kazmierczak et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Factores de riesgo para bacteriemia adquirida en el hospital por Pseudomonas aeruginosa resistente a carbapenémicos en un hospital colombiano
- (2016) Sandra Liliana Valderrama et al. Biomedica
- Ceftazidime/Avibactam and Ceftolozane/Tazobactam: Second-generation β-Lactam/β-Lactamase Inhibitor Combinations
- (2016) David van Duin et al. CLINICAL INFECTIOUS DISEASES
- Impact of hyperglycemia on outcomes of patients with Pseudomonas aeruginosa bacteremia
- (2016) Twisha S. Patel et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Risk factors and influence of carbapenem exposure on the development of carbapenem resistant Pseudomonas aeruginosa bloodstream infections and infections at sterile sites
- (2016) Michelle A. Barron et al. SpringerPlus
- Ceftolozane/Tazobactam: A Novel Cephalosporin/β-Lactamase Inhibitor Combination
- (2015) Jonathan C. Cho et al. PHARMACOTHERAPY
- Influence of carbapenem resistance on mortality of patients with Pseudomonas aeruginosa infection: a meta-analysis
- (2015) Qianqian Liu et al. Scientific Reports
- Antimicrobial Activity of Ceftolozane-Tazobactam Tested against Enterobacteriaceae and Pseudomonas aeruginosa with Various Resistance Patterns Isolated in U.S. Hospitals (2011-2012)
- (2013) David J. Farrell et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- ESCMID guidelines for the management of the infection control measures to reduce transmission of multidrug-resistant Gram-negative bacteria in hospitalized patients
- (2013) E. Tacconelli et al. CLINICAL MICROBIOLOGY AND INFECTION
- P. aeruginosa bloodstream infections among hematological patients: an old or new question?
- (2012) Chiara Cattaneo et al. ANNALS OF HEMATOLOGY
- Risk factors for pan-resistant Pseudomonas aeruginosa bacteremia and the adequacy of antibiotic therapy
- (2012) Felipe F. Tuon et al. Brazilian Journal of Infectious Diseases
- Clinical Characteristics and Risk Factors for Mortality in Patients with Bacteremia Caused by Pseudomonas aeruginosa
- (2012) Tetsuya Horino et al. INTERNAL MEDICINE
- A model to predict mortality following Pseudomonas aeruginosa bacteremia
- (2011) Elizabeth B. Hirsch et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Risk Factors for Mortality in Patients with Pseudomonas aeruginosa Bacteremia: Clinical Impact of Antimicrobial Resistance on Outcome
- (2011) Eun-Jeong Joo et al. Microbial Drug Resistance
- CDC/NHSN surveillance definition of health care–associated infection and criteria for specific types of infections in the acute care setting
- (2008) Teresa C. Horan et al. AMERICAN JOURNAL OF INFECTION CONTROL
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started